DUODOPA_DUOPA
Report
- Report Number
- 3010757606-2025-00182
- Event Type
- Injury
- Date Received
- April 21, 2025
- Date of Event
- March 17, 2025
- Report Date
- April 21, 2025
- Manufacturer
- ABBVIE MEDICAL DEVICE CENTER
- Product Code
- KNT
- PMA / PMN Number
- K142793
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- NURSE
- Health Professional
- Yes
Narratives
REFERENCE NUMBER (B)(4). THE DEVICE INVOLVED IN THE EVENT REMAINED IN THE PATIENT; THEREFORE, A RETURN SAMPLE EVALUATION IS UNABLE TO BE PERFORMED. POST-OP WOUND INFECTION IS A KNOWN COMPLICATION OF A PEG- J TUBE PLACEMENT. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED OR OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.
ON (B)(6) 2025 A PATIENT IN GERMANY UNDERWENT A PROCEDURE FOR THE PLACEMENT OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) TUBE. THE PATIENT RECEIVED AN OPEN PEG IN A CT-GUIDED PROCEDURE. THE INTESTINAL TUBE IS TO BE INSERTED LATER FOR THE TRANSITION TO DUODOPA THERAPY. ON (B)(6) 2025 IT WAS REPORTED THAT ON )B)(6) 2025, A SWAB WAS TAKEN FROM THE PATIENT'S STOMA DUE TO A PERSISTENTLY WEEPING STOMA. THE RESULTS OF THE EXAMINATION WERE AVAILABLE ON (B)(6) 2025: LRE (LINEZOLID-RESISTANT ENTEROCOCCUS) BACTERIA AND E. COLI (ESCHERICHIA COLI) BACTERIA WERE DETECTED. THE PATIENT WAS TREATED WITH ANTIBIOTICS PIPERACILLIN/TAZOBACTAM. IN ADDITION, ANTIBIOTIC GENTAMICIN OINTMENT WAS APPLIED LOCALLY FOR 10 DAYS. SYMPTOMS IMPROVED, AND THE PATIENT WAS DISCHARGED. THE PATIENT IS CURRENTLY RECEIVING PRODUODOPA THERAPY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1741665 | DUODOPA_DUOPA | TUBES, GASTROINTESTINAL (AND ACCESSORIES) | KNT | ABBVIE MEDICAL DEVICE CENTER | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Male | Hospitalization| R | CONCOMITANT PRODUCT NOT REPORTED. |